Curry S, Chow M, Hogle J M
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA.
J Virol. 1996 Oct;70(10):7125-31. doi: 10.1128/JVI.70.10.7125-7131.1996.
The molecular mechanism of cell entry by unenveloped viruses is poorly understood. The picornaviruses poliovirus, human rhinovirus, and coxsackievirus convert to an altered form (the 135S or A particle) upon interaction with receptors on susceptible cells at 37 degrees C. The 135S particle is thought to be a necessary intermediate because it accumulates inside susceptible cells soon after infection and drugs which inhibit conversion of the virus to this form also prevent infection. However, since a variable fraction of the altered 135S particles is reported to elute unproductively from the surface of susceptible cells, their precise role remains unclear. We have found that poliovirus 135S particles can infect Chinese hamster ovary (CHO) and murine L cells, neither of which are susceptible to infection by native poliovirus. The infectivity of the particles in tissue culture appears to be between 10(3) to 10(5) times less than that of poliovirus on HeLa cells. The 135S particle infectivity was not sensitive to RNase but was greatly reduced by proteolytic treatment. Proteolysis specifically removed the newly exposed N terminus of VP1, a feature which has previously been shown to mediate interactions of the particle with lipid membranes. These results demonstrate that although the infectivity of the 135S particle appears to be receptor independent, it nonetheless requires some property associated with the protein coat. In particular, the N terminus of VP1 plays an important role in the infection process. Our findings are consistent with the hypothesis that the 135S particle is an intermediate in the normal cell entry pathway of poliovirus infection.
无包膜病毒进入细胞的分子机制目前仍知之甚少。脊髓灰质炎病毒、人鼻病毒和柯萨奇病毒等小核糖核酸病毒在37摄氏度与易感细胞上的受体相互作用后会转变为一种改变的形式(135S或A颗粒)。135S颗粒被认为是一个必要的中间体,因为它在感染后很快就在易感细胞内积累,并且抑制病毒转变为此种形式的药物也能阻止感染。然而,由于据报道可变比例的改变后的135S颗粒会从易感细胞表面无成效地洗脱,它们的确切作用仍不清楚。我们发现脊髓灰质炎病毒135S颗粒能够感染中国仓鼠卵巢(CHO)细胞和鼠L细胞,而这两种细胞对天然脊髓灰质炎病毒均不易感。这些颗粒在组织培养中的感染性似乎比脊髓灰质炎病毒在HeLa细胞上的感染性低10³至10⁵倍。135S颗粒的感染性对核糖核酸酶不敏感,但蛋白水解处理会使其大大降低。蛋白水解特异性地去除了新暴露的VP1 N端,这一特征先前已被证明介导颗粒与脂质膜的相互作用。这些结果表明,尽管135S颗粒的感染性似乎不依赖受体,但它仍然需要与蛋白衣壳相关的某些特性。特别是,VP1的N端在感染过程中起重要作用。我们的发现与135S颗粒是脊髓灰质炎病毒感染正常细胞进入途径中的中间体这一假设一致。